SCHEMBL286357

SCHEMBL286357

Cc1ccc(CCl)nc1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30918471 1.00
Hydrochloric Acid SCHEMBL126755 0.98 CCR1 (0.46)
Hydrochloric Acid SCHEMBL28024971 0.98 CCR1 (0.46)
Cyanide SCHEMBL28127694 0.94 CCR1 (0.43)
SCHEMBL18682734 0.80 CCR1 (0.52)
SCHEMBL14573460 0.80 CCR1 (0.52)
SCHEMBL469189 0.78
SCHEMBL21166 0.76
SCHEMBL9645202 0.76
SCHEMBL1515370 0.76

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 634 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12398139-B2 Modulators of AMPA receptor signaling CENTRE FOR ADDICTION AND MENTAL HEALTH (CA) 2025-08-26 US disclosed
EP-3935059-B1 MODULATORS OF AMPA RECEPTOR SIGNALING CAMH (CA) 2025-04-23 EP disclosed
US-20250034143-A1 SUBSTITUTED XANTHINES AND METHODS OF USE THEREOF HYDRA BIOSCIENCES, LLC (US) 2025-01-30 US disclosed
US-12144816-B2 Substituted indole Mcl-1 inhibitors VANDERBILT UNIVERSITY (US) 2024-11-19 US disclosed
CN-117720518-B Benzimidazole compound, preparation method thereof, pharmaceutical composition and application 江苏海洋大学 2024-08-13 CN disclosed
US-20240231228-A1 RESIST COMPOSITION AND METHOD OF FORMING PATTERN BY USING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2024-07-11 US disclosed
US-20240228463-A1 SODIUM CHANNEL INHIBITORS AND METHODS OF DESIGNING SAME GENENTECH, INC. (US) 2024-07-11 US disclosed
US-11999716-B2 WDR5 inhibitors and modulators VANDERBILT UNIVERSITY (US) 2024-06-04 US disclosed
US-11958854-B2 Substituted xanthines and methods of use thereof HYDRA BIOSCIENCES, LLC (US) 2024-04-16 US disclosed
CN-117720518-A Benzimidazole compound, preparation method thereof, pharmaceutical composition and application 江苏海洋大学 2024-03-19 CN disclosed
US-4511720-A HYPOTENSIVE AGENTS HOFFMANN-LA ROCHE INC. (US) 1985-04-16 US disclosed
EP-0127763-A1 Tricyclic ethers, process for their preparation, their use and medicaments containing them Byk Gulden Lomberg Chemische Fabrik GmbH (DE) 1984-12-12 EP disclosed
US-4355033-A TREATMENT OF HYPERTENSION HOFFMAN-LA ROCHE INC. (US) 1982-10-19 US disclosed
EP-0002010-B1 DERIVATIVES OF 2-IMINO-IMIDAZOLIDINE, PROCESSES FOR THEIR PREPARATION, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND INTERMEDIATES F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft (CH) 1982-07-14 EP disclosed
EP-0001279-B1 IMIDAZOLE DERIVATIVES THEIR SYNTHESIS AND THEIR PHARMACEUTICAL FORMULATIONS F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft (CH) 1981-09-30 EP disclosed
US-4248880-A IMIDAZOLE OR THIAZOLE DERIVATIVES HOFFMANN-LA ROCHE INC. (US) 1981-02-03 US disclosed
US-4244957-A HYPOTENSIVE AGENTS HOFFMAN-LA ROCHE INC. (US) 1981-01-13 US disclosed
US-4182766-A ANTIULCER AGENTS HOFFMANN-LA ROCHE INC. (US) 1980-01-08 US disclosed
EP-0002010-A1 Derivatives of 2-imino-imidazolidine, processes for their preparation, pharmaceutical compositions containing them and intermediates F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft (CH) 1979-05-30 EP disclosed
EP-0001279-A1 Imidazole derivatives their synthesis and their pharmaceutical formulations F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft (CH) 1979-04-04 EP disclosed